Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables Refunds
Ratios

OptimizeRx (OPRX) Receivables - Net (2016 - 2025)

OptimizeRx's Receivables - Net history spans 16 years, with the latest figure at $32.2 million for Q3 2025.

  • For Q3 2025, Receivables - Net rose 22.41% year-over-year to $32.2 million; the TTM value through Sep 2025 reached $32.2 million, up 22.41%, while the annual FY2024 figure was $38.2 million, 5.4% up from the prior year.
  • Receivables - Net for Q3 2025 was $32.2 million at OptimizeRx, down from $33.5 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $38.2 million in Q4 2024 and bottomed at $1.2 million in Q2 2021.
  • The 5-year median for Receivables - Net is $18.7 million (2022), against an average of $18.0 million.
  • The largest annual shift saw Receivables - Net tumbled 88.75% in 2021 before it surged 1440.91% in 2022.
  • A 5-year view of Receivables - Net shows it stood at $24.8 million in 2021, then dropped by 10.67% to $22.2 million in 2022, then skyrocketed by 63.63% to $36.3 million in 2023, then grew by 5.4% to $38.2 million in 2024, then dropped by 15.66% to $32.2 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Receivables - Net are $32.2 million (Q3 2025), $33.5 million (Q2 2025), and $32.7 million (Q1 2025).